Apr 22, 2021 / 12:00PM GMT
Operator
Welcome to the Hansa Biopharma Interim Report for Q1 2021. (Operator Instructions)
Today, I am pleased to present CEO, Søren Tulstrup. Speakers, please begin.
Søren Tulstrup - Hansa Biopharma AB(publ)-President&CEO
Thank you, operator. Good afternoon. Good morning and welcome to the Hansa Biopharma conference call in the first quarter of 2021.
I'm Søren Tulstrup, CEO of Hansa Biopharma. With me today, I have our CFO, Donato Spota; as well as our Head of Investor Relations, Klaus Sindahl.
Today, we'll review the overall progress and highlights of our business in the first quarter of 2021 as well as the near-term milestones. Our presentation should take 15 minutes. And after that, we'll take your questions.
Now please turn to Slide 2. Please allow me to draw your attention to the fact that I'll be making forward-looking statements during this presentation, and you should therefore apply appropriate caution.
Please turn to Slide 3. Hansa's
Q1 2021 Hansa Biopharma AB Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
